-
Posted: October 30th, 2015, 2:00am GMT
Conditions: Differentiated Thyroid Gland Carcinoma; Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Thyroid Gland Medullary Carcinoma
Interventions: Procedure: Computed Tomography; Procedure: Dual X-ray Absorptiometry; Procedure: Physical Examination; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Cabozantinib; Drug: Lenvatinib
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Completed
-
Posted: October 28th, 2015, 2:00am GMT
Conditions: Metastatic Lung Neuroendocrine Neoplasm; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Lung Small Cell Carcinoma; Metastatic Malignant Neoplasm in the Brain; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
Interventions: Drug: Berzosertib; Other: Quality-of-Life Assessment; Procedure: Therapeutic Conventional Surgery; Radiation: Whole-Brain Radiotherapy
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: October 21st, 2015, 2:00am GMT
Conditions: Metastatic Melanoma; Recurrent Cutaneous Melanoma; Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions: Drug: Ibrutinib; Other: Laboratory Biomarker Analysis; Other: Pharmacogenomic Study; Other: Pharmacological Study
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: October 5th, 2015, 2:00am GMT
Conditions: Breast Cancer; Cholangiocarcinoma; Colorectal Cancer; Head and Neck Neoplasms; Lymphoma, Large-Cell, Anaplastic; Melanoma; Neuroendocrine Tumors; Non-Small Cell Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Primary Brain Tumors; Renal Cell Carcinoma; Sarcomas; Salivary Gland Cancers; Adult Solid Tumor
Interventions: Drug: Entrectinib
Sponsors: Hoffmann-La Roche
Active, not recruiting